Back
NewAmsterdam Pharma Co NV Quote, Financials, Valuation and Earnings
Gold Set to Skyrocket as Fed Slashes Rates
Click here for the details on this incredible opportunity.
Sell
45
NAMS
NewAmsterdam Pharma Co NV
Last Price:
18.93
Seasonality Move:
88.46%
7 Day Trial
ALL ACCESS PASS
$
7
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.NewAmsterdam Pharma Co NV Price Quote
$18.93
-0.20 (-1.05%)
(Updated: October 29, 2024 at 6:55 PM ET)
NewAmsterdam Pharma Co NV Key Stats
Sell
45
NewAmsterdam Pharma Co NV (NAMS)
is a Sell
Day range:
$18.70 - $19.30
52-week range:
$6.60 - $26.35
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
118.25
P/B ratio:
4.44%
Volume:
214.7K
Avg. volume:
238.3K
1-year change:
185.52%
Market cap:
$1.7B
Revenue:
$14.1M
EPS:
$-2.45
How Much Does NewAmsterdam Pharma Co NV Make?
-
How Much Are NewAmsterdam Pharma Co NV's Sales Annually?
NAMS Revenues are $14.1M -
How Much Profit Does NewAmsterdam Pharma Co NV's Make A Year?
NAMS net income is -$176.9M
Is NewAmsterdam Pharma Co NV Growing As A Company?
Data Unavailable
NewAmsterdam Pharma Co NV Stock Price Performance
-
Did NewAmsterdam Pharma Co NV Stock Go Up Last Month?
NewAmsterdam Pharma Co NV share price went up by 17.87% last month -
Did NAMS's Share Price Rise Over The Last Year?
NAMS share price rose by 185.52% over the past 1 year
What Is NewAmsterdam Pharma Co NV 52-Week High & Low?
-
What Is NewAmsterdam Pharma Co NV’s 52-Week High Share Price?
NewAmsterdam Pharma Co NV has traded as high as $26.35 over the past 52 weeks -
What Is NewAmsterdam Pharma Co NV’s 52-Week Low Share Price?
NewAmsterdam Pharma Co NV has traded as low as $6.60 over the past 52 weeks
NewAmsterdam Pharma Co NV Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy NewAmsterdam Pharma Co NV?
-
How Much Debt Does NewAmsterdam Pharma Co NV Have?
Total long term debt quarterly is $0 -
How Much Cash Does NewAmsterdam Pharma Co NV Have?
Cash and short term investments quarterly total is $430.7M -
What Is NewAmsterdam Pharma Co NV’s Book Value Per Share?
Book value per share is 4.30
Is NewAmsterdam Pharma Co NV Cash Flow Positive?
-
What Is NAMS Cash Flow From Operations?
Cash flow from operations (TTM) is -$169.7M -
What Is NewAmsterdam Pharma Co NV’s Cash Flow From Financing?
Cash flow from financing (TTM) is $211.6M -
What Is NewAmsterdam Pharma Co NV’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$606K
NewAmsterdam Pharma Co NV Return On Invested Capital
-
Is Management Doing A Good Job?
NAMS return on invested capital is -50.81% -
What Is NewAmsterdam Pharma Co NV Return On Assets?
ROA measures how assets are converting to revenues and is -44.17% -
What Is NAMS Return On Equity?
ROE is a measure of profitability and is -56.65%
NewAmsterdam Pharma Co NV Earnings Date & Stock Price
-
What Is NewAmsterdam Pharma Co NV's Stock Price Today?
A single share of NAMS can be purchased today for 19.13 -
What Is NewAmsterdam Pharma Co NV’s Stock Symbol?
NewAmsterdam Pharma Co NV trades on the nasdaq under the ticker symbol: NAMS -
When Is NewAmsterdam Pharma Co NV’s Next Earnings Date?
The next quarterly earnings date for NewAmsterdam Pharma Co NV is scheduled on November 13, 2024 -
When Is NAMS's next ex-dividend date?
NewAmsterdam Pharma Co NV's next ex-dividend date is October 30, 2024 -
How To Buy NewAmsterdam Pharma Co NV Stock?
You can buy NewAmsterdam Pharma Co NV shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
NewAmsterdam Pharma Co NV Competitors
-
Who Are NewAmsterdam Pharma Co NV's Competitors?
Below is a list of companies who compete with NewAmsterdam Pharma Co NV or are related in some way:
NewAmsterdam Pharma Co NV Dividend Yield
-
What Is NAMS Dividend Yield?
NewAmsterdam Pharma Co NV’s dividend yield currently is 0% -
What Is NewAmsterdam Pharma Co NV’s Payout Ratio?
NewAmsterdam Pharma Co NV’s payout ratio is 0% -
When Did NewAmsterdam Pharma Co NV Last Pay A Dividend?
The latest dividend pay date is October 30, 2024 -
What Is NewAmsterdam Pharma Co NV’s Dividend Per Share?
NewAmsterdam Pharma Co NV pays a dividend of $0.00 per share
NewAmsterdam Pharma Co NV Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 27.53% |
| Revenue: | 0% | 89.78% |
Analyst Recommendations
| Buy Recommendations: | 5 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 37.66 |
| Upside from Last Price: | 96.85% |